Prescription drug · ANDA
Tetrabenazine NDC 43598-395
Tetrabenazine 25 mg/1 · Tablet · Oral · Dr. Reddys Laboratories Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43598-395-05 | 4359803950543598039505 | 500 TABLET in 1 BOTTLE (43598-395-05)Marketed from Jan 8, 2018 | |
| 43598-395-67 | 4359803956743598039567 | 112 TABLET in 1 BOTTLE (43598-395-67)Marketed from Jan 8, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tetrabenazine
- Generic name (nonproprietary)
- tetrabenazine
- Active ingredients
- Tetrabenazine — 25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Dr. Reddys Laboratories IncNDC labeler code 43598
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209284
- Marketing start
- Listing expires
- Other FDA classes
- Vesicular Monoamine Transporter 2 Inhibitors (Mechanism)
- Identifiers
- Product ID 43598-395_b3ddb23f-3cc7-7c18-982b-970f7acc8766SPL ID b3ddb23f-3cc7-7c18-982b-970f7acc8766SPL set ID ef5f9dd4-945f-ec27-518d-90996a7bd4b6RxCUI 199592, 805464UNII Z9O08YRN8OUPC 0343598395678, 0343598394671
- Pharmacologic class
- Vesicular Monoamine Transporter 2 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443598039505followed by a unit qualifier and the quantityPackage 43598-0395-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington’s disease. Tetrabenazine is a vesicular monoamine transporter 2 (VMAT) inhibitor indicated for the treatment of chorea associated with Huntington’s disease. (1)
Excerpt only. Read the full label for complete information.
About NDC 43598-395
- What is NDC 43598-395?
- 43598-395 is the product NDC for Tetrabenazine, Tetrabenazine 25 mg/1 tablet, listed with the FDA by Dr. Reddys Laboratories Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tetrabenazine.
- What is the active ingredient?
- Tetrabenazine.
- Who is the labeler?
- Dr. Reddys Laboratories Inc, NDC labeler code 43598. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tetrabenazine?
- 21 other product NDCs are listed under this name. See all Tetrabenazine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tetrabenazine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-938 | 23155-0938-63 |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-939 | 23155-0939-63 |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | Precision Dose Inc. | 68094-805 | 68094-0805-10 |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Precision Dose Inc. | 68094-905 | 68094-0905-10 |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-176 | 27241-0176-13 |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-177 | 27241-0177-13 |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Apotex Corp. | 60505-3882 | 60505-3882-07 |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | Apotex Corp. | 60505-3883 | 60505-3883-07 |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-480 | 51407-0480-12 |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-481 | 51407-0481-12 |
Other NDCs under ANDA 209284
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Dr. Reddys Laboratories Inc | 43598-394 |